Kinnos

Brooklyn, United States

Kinnos is a biotechnology company that makes it easy to use disinfectants correctly.

$15.0M raised

May 2023

Series B

Top Investors

Walgreens Boots AllianceVentureWellGolden SeedsPartnership Fund for New York CityNew York Angels

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Kinnos raised?

Kinnos has raised $15.0M in total funding. The most recent round was Series B. The last funding was announced in May 2023.

Who are Kinnos's investors?

Kinnos's investors include Walgreens Boots Alliance, VentureWell, Golden Seeds, Partnership Fund for New York City, New York Angels.

Where is Kinnos headquartered?

Kinnos is headquartered in Brooklyn, United States.

What does Kinnos do?

Kinnos is a biotechnology company that makes it easy to use disinfectants correctly.

What stage is Kinnos at?

Kinnos is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 2, 2023.

MLA

"Kinnos — Funding & Investors." VCBacked, May 2, 2023, https://www.vcbacked.co/company/kinnos. Accessed June 10, 2026.

APA

VCBacked. (2023). Kinnos — Funding & Investors. Retrieved June 10, 2026, from https://www.vcbacked.co/company/kinnos

Wikipedia (cite web)

{{cite web |title=Kinnos — Funding & Investors |url=https://www.vcbacked.co/company/kinnos |website=VCBacked |access-date=June 10, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 2, 2023.